GLP1R and Parkinson disease: Together, these signalling pathways demonstrate that GLP-1 receptor activation produces a convergent neuroprotective program in the brain in which metabolic restoration, trophic support, synaptic stabilisation, mitochondrial enhancement, and inflammatory suppression operate in parallel to counteract PD-related degeneration.